{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2019-09-09T15%3A58%3A11.614Z&min-ddpModified.=2019-09-02T17%3A56%3A10.165Z&max-questionFirstAnswered.=2019-10-29T15%3A20%3A53.607Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?ddpModified.=2019-09-09T15%3A58%3A11.614Z&min-ddpModified.=2019-09-02T17%3A56%3A10.165Z&max-questionFirstAnswered.=2019-10-29T15%3A20%3A53.607Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2019-09-09T15%3A58%3A11.614Z&_metadata=all&min-ddpModified.=2019-09-02T17%3A56%3A10.165Z&max-questionFirstAnswered.=2019-10-29T15%3A20%3A53.607Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&ddpModified.=2019-09-09T15%3A58%3A11.614Z&min-ddpModified.=2019-09-02T17%3A56%3A10.165Z&max-questionFirstAnswered.=2019-10-29T15%3A20%3A53.607Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2019-09-09T15%3A58%3A11.614Z&min-ddpModified.=2019-09-02T17%3A56%3A10.165Z&max-questionFirstAnswered.=2019-10-29T15%3A20%3A53.607Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2019-09-09T15%3A58%3A11.614Z&min-ddpModified.=2019-09-02T17%3A56%3A10.165Z&max-questionFirstAnswered.=2019-10-29T15%3A20%3A53.607Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1143008", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1143008/answer", "answerText" : {"_value" : "<p>In line with other measures around releasing sensitive data in internal Impact Assessments, the final Impact Assessment produced in July 2019 in respect of the new Community Pharmacy Contractual Framework, which did include material relating to ending Medicines Usage Reviews, is not being published at this time.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-09-09T15:26:16.77Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-09-02", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will publish the impact assessment for Medicines Usage Reviews not being included in the new community pharmacy contract.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"}
      }
      , "tablingMemberConstituency" : {"_value" : "North Tyneside"}
      , "tablingMemberPrinted" : [{"_value" : "Mary Glindon"}
      ], "uin" : "284565"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}